RecruitingNCT06043011

Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

Clinical Research Platform on Treatment, Quality of Life and Outcome of Patients With Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms


Sponsor

iOMEDICO AG

Enrollment

2,950 participants

Start Date

Sep 27, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the project is to set up a national, prospective, longitudinal, multicenter registry platform to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with hematological malignancies in Germany.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is a registry — a long-term data collection effort — tracking patients with non-Hodgkin lymphoma (NHL) and other blood cancers over time to understand how these cancers progress, how treatments work in real-world settings, and what factors affect quality of life and survival. **You may be eligible if...** - You are 18 years old or older - You have been diagnosed with a non-Hodgkin lymphoma or other related blood cancer - You are either alive and can provide written consent, or your data can be collected retrospectively **You may NOT be eligible if...** - You have not received any systemic therapy (drug treatment) for your lymphoma Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRoutine care as per site standard.

Physician's choice according to patient's needs.


Locations(1)

Praxis für Interdisziplinäre Hämatologie und Onkologie

Freiburg im Breisgau, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06043011


Related Trials